Saturday, August 2, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Insmed’s Drug for Rare Lung Disease Achieves ‘home Run’ in Mid-stage Trial

June 10, 2025
in Health News
Share on FacebookShare on Twitter


(Reuters) -Insmed said on Tuesday that its experimental drug significantly reduced blood pressure in the lungs and improved exercise capacity in patients in a mid-stage study, lifting its shares up as much as 30%.

The potential success of the inhaled drug, treprostinil palmitil, would set Insmed on track to compete with larger rival Merck’s injectable treatment Winrevair and offer a convenient treatment option for patients.

Leerink Partners analyst Joseph Schwartz said the data is “prostanoid of choice for patients.”

The 102-patient study found that the drug helped reduce blood pressure in the patients’ lungs by 35%, compared with a placebo.

It also helped improve the patients’ ability to walk by an average of 35.5 meters and reduced levels of a protein associated with heart stress by 60%.

Coughing was reported as an adverse event in 40.6% of patients receiving the drug. However Guggenheim analyst Vamil Divan said it was “within the range of what should be expected” for an inhaled product.

The company plans to discuss the data with the U.S. Food and Drug Administration and initiate a late-stage trial for the drug in patients with pulmonary arterial hypertension (PAH) — a rare disease caused by a constriction of arteries in the lungs, leading to high blood pressure – in early 2026.

Around 1,000 new cases of PAH are diagnosed each year in the U.S., according to the American Lung Association.

RBC Capital Markets analyst Leonid Timashev said the data “comes in well above set bars” and as “our perceived home-run scenario,” estimating peak sales of $1.8 billion for the drug by 2034.

Current PAH treatments include Merck’s injectable Winrevair, Liquidia’s inhaled Yutrepia and United Therapeutics’ Tyvaso.

Liquidia and United Therapeutics’ PAH drugs “have sometimes been a challenge for patients to use” due to their safety concerns, Timashev added.

Shares of Liquidia and United Therapeutics were down over 23% and 16%, respectively.

Merck’s Winrevair, acquired through its $11.5 billion Acceleron Pharma purchase in 2021, generated $419 million in sales in 2024.

(Reporting by Kamal Choudhury in Bengaluru; Editing by Maju Samuel)



Source link : https://www.medscape.com/s/viewarticle/insmeds-blood-pressure-drug-meets-main-goal-mid-stage-trial-2025a1000fjn?src=rss

Author :

Publish date : 2025-06-10 11:24:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

IBM says it will build a practical quantum supercomputer by 2029

Next Post

Long-Acting Muscarinic Antagonists Aid Asthma Care in Kids

Related Posts

Health News

Questions Abound About Treating AMD, Geographic Atrophy at the Same Time

August 2, 2025
Health News

Which Physicians Have a Higher Mortality Risk?

August 2, 2025
Health News

HPV and Skin Cancer; Polygenic Risk Score for Obesity; Rare Flu Complication in Kids

August 2, 2025
Health News

War Is a Global Health Catastrophe

August 2, 2025
Health News

An Ohio Couple Welcomes a Baby Boy From a Nearly 31-Year-Old Frozen Embryo

August 2, 2025
Health News

Brisk Walking May Help You Live Longer

August 2, 2025
Load More

Questions Abound About Treating AMD, Geographic Atrophy at the Same Time

August 2, 2025

Which Physicians Have a Higher Mortality Risk?

August 2, 2025

HPV and Skin Cancer; Polygenic Risk Score for Obesity; Rare Flu Complication in Kids

August 2, 2025

War Is a Global Health Catastrophe

August 2, 2025

An Ohio Couple Welcomes a Baby Boy From a Nearly 31-Year-Old Frozen Embryo

August 2, 2025

Brisk Walking May Help You Live Longer

August 2, 2025

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

August 1, 2025

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

August 1, 2025
Load More

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version